Searched for
GERMAN PHARMA CO
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...- What running a business in India actually looks like: Nightmare of CEOs these days is conversion of commercial disputes into criminal casesA corporate crisis manager describes how business disputes in India are increasingly being turned into criminal cases, exposing executives ...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Sun Pharma scouting for innovative therapies to boost India businessApproved by the Indian drug regulator in May 2023, sovateltide can be administered within 24 hours for the treatment of ischemic stroke, al...
- Emami partners with German Hevert-ArzneimittelAs per the agreement, Hevert-Arzneimittel products will be available in 400 homoeopathy medicine retail outlets across diverse distribution...
- Zydus Cadila loses two popular brandsDulcolax and Buscopan had been present for the past many decades in India, initially through an agreement that Boehringer Ingelheim had wit...
- Ess Dee Aluminium enters into tie-up with Germany’s Chemnitz University for R&D in packagingThe tie up aims to improve the existing products in terms of quality, price and overall performance and to develop new products based on th...
- Bayer challenges IPAB’s compulsory licence order to Natco Pharma on cancer drug Nexavar“We introduce the product after years of research and investment, while companies like Natco merely copy and manufacture the product,” said...
- German pharma company Boehringer Ingelheim remains bullish on R&D and India"I am quite convinced that as more and more Indian generic companies start doing their own research, I think it will change the conditions ...
- Sun Pharma up 3% on bourses on news of tie up with US drug coShares of Sun Pharma touched Rs 455.90, a jump of 3 per cent over its previous closing price on the Bombay Stock Exchange.
- Cipla in talks to supply drugs to Germany’s BIBoehringer Ingelheim in talks with Cipla for supply of generic drugs to the $17-bn German coa for two drugs.
- Open offer to Dabur Pharma shareholders rescheduledDabur Pharma on Tuesday said the open offer to its shareholders by German firm Fresenius Kabi has been rescheduled and will now begin on Ju...
- German co Fresenius Kabi picks up 73% in Dabur PharmaGerman co Fresenius Kabi acquired the stake in Dabur Pharma for around Rs 872 cr. With this, the Burman family exits pharmaceutical biz. Go...
- Biocon picks up 70% in German pharma co AxiCorp for e30 mnThe deal will enable the Bangalore-based player to market its injectible insulin, generics, biosimilars and biologics in Europe.
- Dr Reddy's plans to file 20 new drug applicationsDr Reddy’s Laboratories is betting on the US market and plans to file about 20 more ANDAs (Abbreviated New Drug Applications) in 2008. Reso...
- Biocon in talks with Bayer for drug developmentTwo pharma cos may sign pact involving co-development of new biotech drugs & research services.
- French co buys IP rights from LupinThe Mumbai-based pharma co will receive 20 mn euros from Servier Laboratories for its process patents.
- Milestone for GlenmarkGlenmark’s out-licensing deal with the German pharma major, Merck KGaA, for its diabetes molecule, a DPP-IV inhibitor, is an important mile...
Load More
